Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cytochrome b5 type A pseudogene 2 (CYB5AP2) is a human pseudogene, defined as a genomic DNA sequence related to the functional CYB5A gene but rendered inactive by mutation or truncation. Pseudogenes like this do not code for functional proteins, though in some cases pseudogene transcripts may exert regulatory effects on parental genes via RNA-based mechanisms, such as sponging miRNAs or producing antisense transcripts. However, there is no direct evidence that CYB5AP2 has such a function or that it is involved in any human disease or serves as a therapeutic target[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytochrome b5 type A pseudogene 2 (CYB5AP2).